CTRI/2025/02/080618尚未招募不适用
To assess the safety and efficacy of Hair care formulation in terms of Anti dandruff effect
Onesto Labs Pvt. Ltd.1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年2月24日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Anti-dandruff effect
研究概览
简要总结
OBJECTIVE: The aim of the study is to assess the safety and efficacy of Hair care formulation in terms of Anti-dandruff effect.
The evaluation is performed using: Consumer Test - Self Assessment Questionnaire
POPULATION: 60 males and 40 females’ subjects, aged between 18-35 years, having moderate to severe dandruff will be selected for this study.
STUDY DURATION & KINETICS: The study will lasts for 42 days following the first application of the product.
Observations will be done on T0, T+1 days, T+7 days, T+14 days, T+28 days and T+42 days
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 35.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Indian male and female subjects.
- •2.Healthy subjects.
- •3.Skin is healthy on the studied anatomic unit 4.Having moderate to severe dandruff.
排除标准
- •Taking part in another study liable to interfere with this study.
结局指标
主要结局
Anti-dandruff effect
时间窗: Baseline, Day 1, Day 7, Day 14, Day 28 and Day 42
次要结局
未报告次要终点
研究者
Dr Pooja Yadav
MASCOT-SPINCONTROL India Pvt. Ltd.
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Study to check if a hair product helps reduce hair fall and improve hair growth.CTRI/2025/10/096191Sun Pharmaceutical Industries Ltd.36
已完成
不适用
Evaluation of the Efficacy and Safety of a Hair Care Formulation for Enhancing Hair GrowthCTRI/2025/01/078896Eliea Wellness36
尚未招募
2 期
Evaluation of efficacy of Polyherbal Formulations in Management of Chronic Telogen Effluvium in healthy Females.CTRI/2025/09/094064Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital44
已完成
不适用
Clinical Study to Evaluate Effect of Shampoo in Subjects With Hair Loss.Androgenetic AlopeciaTelogen EffluviumNCT07433933Lacer S.A.40
尚未招募
不适用
Study to check the safety of hair care products on humans.CTRI/2025/10/096562Lotus Herbals Pvt. Ltd.220